BRPI0606869A2 - derivados anti-helmìnticos de imidazol-tiazol - Google Patents

derivados anti-helmìnticos de imidazol-tiazol

Info

Publication number
BRPI0606869A2
BRPI0606869A2 BRPI0606869-3A BRPI0606869A BRPI0606869A2 BR PI0606869 A2 BRPI0606869 A2 BR PI0606869A2 BR PI0606869 A BRPI0606869 A BR PI0606869A BR PI0606869 A2 BRPI0606869 A2 BR PI0606869A2
Authority
BR
Brazil
Prior art keywords
compound
derivatives
thiazole
imidazole
novel
Prior art date
Application number
BRPI0606869-3A
Other languages
English (en)
Inventor
Paulus Joannes Lewis
Kathleen Marie Jeanne Alice Vlaminck
Pierre Josef Hektor Valere Ottevaere
Oscar Franz Joseph Vanparijs
Jan Heeres
Paul Adriaan Jan Janssen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0606869A2 publication Critical patent/BRPI0606869A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

DERIVADOS ANTI-HELMINTICOS DE IMIDAZOL-TIAZOL. A presente invenção refere-se ao novo composto anti-helmíntico [3-(2 ,3,5 ,6-tetraidro-im idazo[2, 1 -b]tiazol-6-iI)-fenil]-am ida do ácido tetraidrofuran-2-carboxílico e os sais de adição de ácido e as formas estereoquimicamente isoméricas farmaceuticamente aceitáveis dos mesmos, bem como a composições farmacêuticas compreendendo o referido novo composto, processos de preparação dos referidos composto e composições, e o uso dos mesmos como um medicamento, em particular no tratamento e prevenção de infecções por endo e ectoparasitas em animais de sangue quente.
BRPI0606869-3A 2005-01-28 2006-01-26 derivados anti-helmìnticos de imidazol-tiazol BRPI0606869A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100580 2005-01-28
PCT/EP2006/050460 WO2006079642A1 (en) 2005-01-28 2006-01-26 Anthelmintic imidazol-thiazole derivates

Publications (1)

Publication Number Publication Date
BRPI0606869A2 true BRPI0606869A2 (pt) 2009-07-21

Family

ID=34938598

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606869-3A BRPI0606869A2 (pt) 2005-01-28 2006-01-26 derivados anti-helmìnticos de imidazol-tiazol

Country Status (17)

Country Link
US (1) US20080287511A1 (pt)
EP (1) EP1844055A1 (pt)
JP (1) JP2008528550A (pt)
KR (1) KR20070106990A (pt)
CN (1) CN101107255A (pt)
AR (1) AR052365A1 (pt)
AU (1) AU2006208712A1 (pt)
BR (1) BRPI0606869A2 (pt)
CA (1) CA2589221A1 (pt)
EA (1) EA011024B1 (pt)
IL (1) IL184862A0 (pt)
MX (1) MX2007009168A (pt)
NO (1) NO20074371L (pt)
NZ (1) NZ555541A (pt)
PA (1) PA8661101A1 (pt)
TW (1) TW200640933A (pt)
WO (1) WO2006079642A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2561105T3 (es) 2011-08-18 2016-02-24 Nippon Shinyaku Co., Ltd. Derivado heterocíclico como inhibidor de prostaglandina E sintasa microsómica (mPGES)
CN102675346A (zh) * 2012-05-28 2012-09-19 重庆大学 一种左旋咪唑有机酸盐，其合成方法和它的药物组合物
JP7210483B2 (ja) * 2017-06-30 2023-01-23 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規アザキノリン誘導体
US11254661B2 (en) * 2017-08-04 2022-02-22 Bayer Animal Health Gmbh Quinoline derivatives for treating infections with helminths
CN111138457A (zh) * 2019-12-19 2020-05-12 山东国邦药业有限公司 一种盐酸四咪唑的合成方法
CN112358490B (zh) * 2020-12-10 2021-11-09 山东国邦药业有限公司 一种盐酸四咪唑的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1365515A (en) * 1971-09-03 1974-09-04 American Cyanamid Co 6-tetrahydro imidazol/2 1-b/thiazoles
US4014892A (en) * 1972-09-14 1977-03-29 American Cyanamid Company 6-Substituted amino phenyl-2,3,5,6-tetrahydro[2,1-b]thiazoles
ZA735753B (en) * 1972-09-14 1974-07-31 American Cyanamid Co Resolution of 6-substituted amino phenyl-2,3,5,6-tetrahydro(2,1-b)thiadiazoles

Also Published As

Publication number Publication date
EP1844055A1 (en) 2007-10-17
EA200701601A1 (ru) 2007-12-28
AR052365A1 (es) 2007-03-14
JP2008528550A (ja) 2008-07-31
CN101107255A (zh) 2008-01-16
MX2007009168A (es) 2007-08-14
EA011024B1 (ru) 2008-12-30
WO2006079642A1 (en) 2006-08-03
CA2589221A1 (en) 2006-08-03
US20080287511A1 (en) 2008-11-20
PA8661101A1 (es) 2006-09-22
NO20074371L (no) 2007-08-28
NZ555541A (en) 2009-08-28
KR20070106990A (ko) 2007-11-06
TW200640933A (en) 2006-12-01
AU2006208712A1 (en) 2006-08-03
IL184862A0 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
BRPI0716171A8 (pt) Composto, composição farmacêutica e uso de um composto
UA103272C2 (uk) 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
NZ596579A (en) Bace inhibitors
NO20073722L (no) Farmasoystiske sammensetniger omfattende bendamustin
BR112012017269A2 (pt) compostos heterocíclicos tricíclicos, composições e métodos de uso dos mesmos
BRPI0911035A2 (pt) ativadores de pirrolidinona glicoquinase
EA201001368A1 (ru) Гетероциклические производные мочевины и способы их применения-211
GEP201606506B (en) Quinoline amide m1 receptor positive allosteric modulators
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
GEP20156348B (en) Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
IT1393402B1 (it) Uso di enhancer eventualmente con riboflavina, nonche' relative composizioni oftalmiche per cross-linking corneale del cheratocono o di altre patologie ectasiche corneali
EA201490774A1 (ru) Новые производные оксазина и их применение при лечении заболевания
BR112013031510A2 (pt) [1,3]oxazinas
ME01456B (me) Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola
NO20091409L (no) Pyridin-3-yl-derivater som immunmodulerende midler
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
PE20120648A1 (es) Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1
BR112017027411A2 (pt) inibidores de nadph oxidase 4
CL2008002689A1 (es) Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia.
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
BR112014006763A2 (pt) n-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexa-hidro-ciclopenta[e][1,3]oxazin-4-il)-fenil)-amidas como inibidores de bace1
BR112014015630A2 (pt) fluorometil-5,6-di-hidro-4h-[1,3]oxazinas
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]